Literature DB >> 12832547

Axo-axonic structures in the medial prefrontal cortex of the rat: reduction by prenatal exposure to cocaine.

Bret A Morrow1, John D Elsworth, Robert H Roth.   

Abstract

The cognitive deficits associated with prenatal exposure to cocaine have been hypothesized to be the results of changes in the anatomy and function of the frontal cortex. In this study, pregnant dams were treated with cocaine (3 mg/kg i.v. twice a day) and the resulting adolescent (postnatal day, approximately 45) male offspring were killed for immunocytochemical determination of the total linear measure, number, location, and lengths of inhibitory GABA transporter-1 immunoreactive axo-axonic structures commonly called "candles" or "cartridges" in the medial prefrontal cortex. These inhibitory structures are the axon terminals of GABAergic cells that impinge on the initial axon segments of excitatory pyramidal neurons. We report that prenatal cocaine exposure decreased the number of these inhibitory candles. The greatest reduction of candles was observed in the ventral prelimbic cortex. Additionally, there was a subtle difference in the pattern of distribution of candles, namely the depth of the initial candle in the ventral portions of the prefrontal cortex was greater in rats exposed to prenatal cocaine. However, there was no overt change in the number of cells that were immunoreactive for the calcium-binding protein parvalbumin, an indicator of a subset of GABAergic interneurons that includes axo-axonic chandelier cells. We conclude that exposure to cocaine in utero disrupts the development of the axo-axonic cells in the prefrontal cortex and this disruption could contribute to the cognitive deficits reported with prenatal cocaine exposure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832547      PMCID: PMC6741213     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  9 in total

1.  Increased "default mode" activity in adolescents prenatally exposed to cocaine.

Authors:  Zhihao Li; Priya Santhanam; Claire D Coles; Mary Ellen Lynch; Stephan Hamann; Scott Peltier; Xiaoping Hu
Journal:  Hum Brain Mapp       Date:  2011-05       Impact factor: 5.038

2.  Differential laminar effects of amphetamine on prefrontal parvalbumin interneurons.

Authors:  M M Morshedi; Gloria E Meredith
Journal:  Neuroscience       Date:  2007-08-14       Impact factor: 3.590

Review 3.  The anatomy of co-morbid neuropsychiatric disorders based on cortico-limbic synaptic interactions.

Authors:  S Totterdell
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

4.  Specificity of prenatal cocaine exposure effects on cortical interneurons is independent from dopamine D1 receptor co-localization.

Authors:  Barbara L Thompson; Gregg D Stanwood; Pat Levitt
Journal:  J Chem Neuroanat       Date:  2010-01-18       Impact factor: 3.052

Review 5.  Cocaine-induced neurodevelopmental deficits and underlying mechanisms.

Authors:  Melissa M Martin; Devon L Graham; Deirdre M McCarthy; Pradeep G Bhide; Gregg D Stanwood
Journal:  Birth Defects Res C Embryo Today       Date:  2016-06

6.  Cocaine exposure decreases GABA neuron migration from the ganglionic eminence to the cerebral cortex in embryonic mice.

Authors:  James E Crandall; Hazel E Hackett; Stuart A Tobet; Barry E Kosofsky; Pradeep G Bhide
Journal:  Cereb Cortex       Date:  2004-03-28       Impact factor: 5.357

7.  Cocaine exposure in utero alters synaptic plasticity in the medial prefrontal cortex of postnatal rats.

Authors:  Hui Lu; Byungkook Lim; Mu-ming Poo
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

8.  Children's cognitive ability from 4 to 9 years old as a function of prenatal cocaine exposure, environmental risk, and maternal verbal intelligence.

Authors:  David S Bennett; Margaret Bendersky; Michael Lewis
Journal:  Dev Psychol       Date:  2008-07

Review 9.  A meta-analysis of animal studies on disruption of spatial navigation by prenatal cocaine exposure.

Authors:  George H Trksak; Stephen J Glatt; Farzad Mortazavi; Denise Jackson
Journal:  Neurotoxicol Teratol       Date:  2007-06-30       Impact factor: 3.763

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.